Yeda is a Berlin-based soft robotics company developing an individualised device for supporting women’s pelvic floor. This is mostly relevant for those suffering from pelvic floor dysfunctions (PFD) and urinary incontinence, which are 50% of all women globally. The team developed an end-to-end solution that offers immediate support based on a silicone inflatable device and long-term training over an app, which is a differentiator from other training devices or traditional pessaries. Yeda is a silicone device designed for women with a weak pelvic floor to be used in common activities of daily l ..read more

?  9-10 October 2024 ? Messe Basel, Switzerland BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. Over the years they have fostered strong relationships with local partners such as the Canton of Basel, Novartis, Roche and various incubators to cover the full pipeline of drug development. The congress features senior speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems and academic groups creating endless networking opportunities. In 2024 BioTe ..read more

Recognizing the critical importance of supporting women's health and femtech startups, back in 2019, our team embarked on a mission to provide female founders with the resources they need to thrive and grow their businesses.  On top of our content library, job board, list of key events to attend and startup programs to apply, we are now thrilled to announce the launch of our curated list featuring 150+ venture capital funds actively investing in women's health and femtech. Women's health has long been a neglected and underfunded area within the broader landscape of healthcare innovation ..read more

The first-of-its-kind dedicated workplace support programme for people who suffer with endometriosis has been launched by women's health startup frendo to coincide with Endometriosis Awareness Month. Endometriosis is a chronic disease, which if left untreated, can cause organ dysfunction, chronic pain and infertility. It is estimated that one in 10 women of reproductive age in the UK suffer with endometriosis. Research by frendo found that one in five (20%) women feel their workplaces are unsupportive of chronic health conditions[2], and while almost a quarter (24%) of workplaces provide ..read more

Mira, a hormonal health company providing integrative care and hormonal testing for women, announced the first nationwide Sex Hormones Awareness Week, set to take place from February 18th to February 24th, 2024. With this initiative, Mira seeks to educate people about their sex hormones so that they can make informed decisions about their health. Even though society has made tremendous technological and medical advances over the past few decades, in 2023, women are still 20% more likely to be misdiagnosed compared to men. Despite women having a 5-year longer life expectancy than men, they endu ..read more

Menopause 2.0 is a global virtual conference covering menopause as a societal, economic, workplace and healthcare issue.  Join us for a day of insightful talks, educational panels, thought-provoking discussions, groundbreaking research and a showcase of best practices and innovations.  We are bringing together key stakeholders: researchers, scientists, clinicians, startup founders, pharma, investors, policymakers, organisations, and media to have a conversation about menopause.  Some of the topics we will be covering include: Menopause and mental health Menopause and workpla ..read more

Leading women’s health startup, ELANZA Wellness, has announced its first crowdfunded launch from the company’s newly formed endometriosis care division. The EverythingEndo app is designed to help people with endometriosis self-manage symptoms from home, to complement clinical care. The fundraising campaign is live on Kickstarter from today.  “This is an invitation for individuals affected by endometriosis to have a real impact on shaping a platform for them that resonates with their unique needs, actively participating in the process of backing and building it,” says ELANZA Wellness co-fo ..read more

Bone Health Technologies announced that the U.S. Food and Drug Administration (FDA) has granted clearance for OsteoboostTM, the first non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density).  Osteoboost is a wearable belt device, worn on the hips, that delivers targeted, calibrated vibration to the lumbar spine and hips. Osteoboost is indicated to reduce bone strength and density decline in postmenopausal women and is the first and only solution specifically designed to improve bone health during osteopenia. This break ..read more

Digital Health Companies Can Now Rely on TBD Health’s Industry-Leading Testing and Treatment Both at Home and In-Person Care Hubs  TBD Health, a hybrid sexual healthcare provider revolutionizing the medical landscape through unparalleled digital and in-person clinical care, today announced its entry into the B2B healthcare market by offering fellow digital health companies like FOLX Health and Wisp access to its at-home STD/STI test kits, diagnostics lab, and clinics. “At TBD Health, we firmly believe that healthcare organizations should stand together in order to offer patients unparalle ..read more

Despite the anticipated growth of the European digital health industry, valued at £38.1 billion in 2023, founders still face significant challenges in accessing funding. In the UK, 80% of Venture Capitalist (VC) funding for AI has gone to all-male teams over the last decade, and less than 2% of VC start-up funding is allocated towards companies with founders who identify as being from an ethnic minority. For businesses founded by neurodiverse or disabled individuals, the outlook is even more concerning—a report from the Disability Policy Centre think tank estimates their ventures are 400 time ..read more